Skip to main content
  • 856 Accesses

Abstract

Malignant pleural mesothelioma (MPM) is the most common primary neoplasm of the pleura. It is 1,000 times more common in the population exposed to asbestos. Its incidence has been increasing and is expected to do so until 2020. In Western Europe, 250,000 men are expected to die from MPM by 2030.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sugarbaker DJ, Strauss GM, Lynch TJ et al (1992) Node status has prognostic significance in the multimodality therapy of diffuse, malignant MPM. J Clin Oncol 11:1172–1178

    Google Scholar 

  2. Sugarbaker DJ, Flores RM, Jaklitsch MT et al (1999) Resection margins, extrapleural nodal status and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural MPM: results in 183 patients. J Thorac Cardiovasc Surg 117:54–63

    Article  PubMed  CAS  Google Scholar 

  3. Bénard F, Sterman D, Smith RJ et al (1998) Metabolic imaging of malignant pleural MPM with fluorodeoxyglucose positron emission tomography. Chest 114:713–722

    Article  PubMed  Google Scholar 

  4. Schneider DB, Clary-Macy C, Challa S et al (2000) Positron emission tomography with F18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural MPM. J Thorac Cardiovasc Surg 120:128–133

    Article  PubMed  CAS  Google Scholar 

  5. Carretta A, Landoni C, Melloni G et al. (2000) 18-FDG PET in the evaluation of malignant pleural diseases — a pilot study. Eur J Cardiothorac Surg 17:377–383

    Article  PubMed  CAS  Google Scholar 

  6. Bénard F, Sterman D, Smith RJ et al (1999) Prognostic value of FDG PET imaging in malignant pleural MPM. J Nucl Med 40:1241–1245

    PubMed  Google Scholar 

  7. Rusch VW, Venkatraman ES (1999) Important prognostic factors in patients with malignant pleural MPM, managed surgically. Ann Thorac Surg 68:1799–1804

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Italia

About this chapter

Cite this chapter

Steinert, H.C. (2011). PET-CT Evaluation of the Pleura and Chest Wall. In: Hodler, J., von Schulthess, G.K., Zollikofer, C.L. (eds) Diseases of the Heart and Chest, Including Breast 2011–2014. Springer, Milano. https://doi.org/10.1007/978-88-470-1938-6_33

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1938-6_33

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1937-9

  • Online ISBN: 978-88-470-1938-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics